SAN DIEGO--(BUSINESS WIRE)-- #ISO27001--Genialis, the therapeutic intelligence company, today announced GenialisTM BioBridge to help pharmaceutical sponsors translate clinical results generated in Chinese patient populations into biomarker-ready assets for Western trials and regulatory submissions. The global drug development landscape has shifted with many innovative oncology therapies now being discovered and clinically validated first in China before being licensed for development in North Am